Hemodynamic Effects of Local Anesthesia and its Possible Correlation with Chromogranin A

Maha T. Al–Saffar¹, Tahani A. AL-Sandook² and Mahmoud Y. Taha^1,

¹Department of Dental Basic Science, College of Dentistry, Mosul University, Mosul, Iraq

²Iraq Cultural Attachi, Washington, USA

Cite this paper:
Maha T. Al–Saffar, Tahani A. AL-Sandook and Mahmoud Y. Taha. Hemodynamic Effects of Local Anesthesia and its Possible Correlation with Chromogranin A. American Journal of Pharmacological Sciences. 2014; 2(1):12-17. doi: 10.12691/ajps-2-1-3

Abstract

Aim: To study the effects of local anesthesia on blood pressure in patients undergo extraction of maxillary teeth under infiltration local anesthesia and to compare the level of salivary chromogranin A before and after administration of local anesthesia and its possible correlation with hemodynamic effects of local anesthesia. Materials and Methods: A total of 26 patients (18 female, 8 male) who need tooth extraction under infiltration local anesthesia were examined in two situations (pre and post local anesthetic administration). For each patient salivary sample was collected by salivette to estimate the level of chromogranin A using ELISA Kits. For all patients, the blood pressure and pulse rate were measured before and after administration of local anesthesia using automatic blood pressure recorder. Results: the results showed significant differences between salivary chromogranin A for patients before the administration of local anesthesia (580.33 ± 130.42) ng/ml and after the administration of local anesthesia (674.51+ 130.93) ng/ml with p < 0.05. The results also showed that the mean value of blood pressure (systolic and diastolic blood pressure) lowered after administration of local anesthesia but with no significant differences (p > 0.05) with pre –local anesthetic value. The pulse rate was increase in it is value after local anesthetic administration with a significant differences (p < 0.05) than pre – anesthetic value. Conclusions: tooth extraction and administration of infiltration local anesthesia caused hypotension with no significant effect (p > 0.05) while it caused increase in pulse rate with a significant effect (p < 0.05). Administration of infiltration local anesthesia caused significant effects on salivary chromogranin A levels, also this study showed that there was significant inverse correlation between systolic blood pressure and chromogranin A levels(p < 0.05) after administration of infiltrations local anesthesia during dental treatments (tooth extraction).

Keywords:
salivary chromogranin A local anesthesia blood pressure

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	American Academy of Pediatric Dentistry (2009). Guide line on use of local anesthesia for pediatric dental patient. Reference manual, 34 (6):183-90.
[2]	Locker D, Liddell A, and Shopira D (1999). Diagnostic categories of dental anxiety: a population–based study. Behav Res Ther, 37:25-37.
[3]	Helle KB (2004). The granin family of uniquely acidic proteins of the diffuse neuroendocrine system,comparative and functional aspect . Biol Rev (comb), 79:769-794.
[4]	Vera J, Camoda M, and Machedo J (2011). Chromogranin A and B are key pprotiens in amine accumulation, but the catecholamine secretary pathway is conserved without them. FASEB, 18:Abstract
[5]	Kanno T, Asada N, and Yanase H (1999). Salivary secretion of highly concentrated chromogranin A in response to noradrenalin and acetylcholine in isolated and per fused rat. submandibular glands. Exp Physiol, 84:1073-83.
[6]	Obayashi K, Sato H, and Shimazzaki R (2008). Salivary chromogranin A: useful and quantitative biochemical marker of affective state in patients with any atrophic lateral sclerosis. Int Med, 47(21):1875-79.
[7]	Saruta J, Tsukinoki K, and Sasaquri K (2005). Expression and localization of chromogranin A gene and protein in human submandibular gland. Cell Tissue Organs, 180(4).237-44.
[8]	Malamed ST (2013). Technique of maxillary anesthesia In Malamed ST. Hand book of local anesthesia. 6th edition, Mosby Elsevir Inc, New York, USA; p188-215.
[9]	Kanegane K, Penha S, Borsatti M (2003). Dental anxiety in an emergency dental service. Rev Saude Publica, 37:786-792.
[10]	Nater YM, Rohleder N, and Gaab J (2005). Human salivary alpha amylase reactivity in a psychosocial stress paradiagn. Int J Psychophysiol, 55(3):333-341.
[11]	Meechan J, Cole B, and Welbury R (2001). The influence of two different dental local anesthetic solutions on the haemodynamic responses of children undergoing restorative dentistry: a randomized, single- blind, split- mouth study. Br Dent J, 190(9):502-504.
[12]	Sotunmbi PT and Arotiba JT (2005). A manual of anaesthesia for dental and maxillofacial surgery. 1st ed., Ambod Publishers, Nigeria: 72-102.
[13]	Meechan JG, Parry G, and Rattray DT (2002). Effects of dental local anaesthetics in cardiac transplant recipients. Br Dent J, 192:161-3.
[14]	Viana AM, Campos AC, and Morlin MT (2005). Plasma catecho lamine concentrations and hemodynamic responses to vasoconstrictor during conventional or Gow-Gates mandibular anesthesia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 100:415-9.
[15]	Cáceres MT, Ludovice AC, and Brito FS (2008). Effect of local anesthetics with and without vasoconstrictor agent in patients with ventricular arrhythmias. Arq Bras Cardiol, 91:128-33, 142-7.
[16]	Kameyama K, Watanabe S, and Kano T (2008). Effects of nasal application of an epinephrine and lidocaine mixture on the hemodynamics and nasal mucosa in oral and maxillofacial surgery. J Oral Maxillofac Surg, 66:2226-32.
[17]	Yang JJ, Wang TY, and Wang J (2005). Marked hypotension induced by adrenaline contained in local anaesthetic. Laryngoscope 115(2):348-352.
[18]	Bortoluzzi MC, Manfro R, and Nardi A (2010). Glucose levels and hemodynamic changes in patients submitted to routine dental treatment with and without local anesthesia. Clinics, 65(10):975-978.
[19]	Neal JM. (2003). Effects of epinephrine in local anesthetics on the central and peripheral nervous systems: Neurotoxicity and neural blood flow. Reg Anesth Pain Med, 28:124-34.
[20]	Brown RS, Rhodus NL. (2005). Epinephrine and local anesthesia revisited. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 100:401-8.
[21]	Haghighat A (2006). Hemodynamic effects of 2% lidocaine with 1:80000 epinephrine in inferior alveolar block. Dent Res J, 3(1):4-7.
[22]	Chitre AP. (2010). Manual of local anesthesia in Dentistry.2nd ed. Jaypee Brothers Medical Publishers. pp. 3-90.
[23]	Sia S, Sarro F, and Lepri A (2003). The effect of exogenous epinephrine on the incidence of hypotensive/ bradycardic events during shoulder surgery in the sitting position during interscalene block. Anesth Analog, 97: 583-588.
[24]	Shaban B, Moradi M, and Nejat AH (2012). Hemodynamic Effect of 2%Lidocaine with 1:80,000 Epinephrine Infiltration in Maxillofacial Surgeries under General Anesthesia. JDM, 2(1):16-25.
[25]	Shibata M, Kawai M, and Matsukura T (2013). Salivary biomarkers are not suitable for pain assessment in newborns. Early human development, 89:503-506.
[26]	Mitsuhat C, Ohara Y, and Tachikake M (2012). Effectiveness of salivary chromogranin A as a stress index in young children during dental treatment. Pediatric Dental Journal, 22(2):163-169.
[27]	Kudo M (2005). Initial injection pressure for dental local anesthesia: effects on pain and anxiety. Anesth Prog, 52(3):95-101.
[28]	Lyby PS, Aslaksen PM, and Flaten MA (2010). Is fear of pain related to placebo analgesia? Journal of Psychosomatic Research, 68(4): 369-377.
[29]	Koh DQ, and Koh GH (2007). The use of salivary biomarkers in occupational and enviremental medicine. Occup Environ Med, 64:202-210.
[30]	Muhata SK, Mahata M, and Parmer RJ (1999). Desensitization of catecholamine release. The Journal of Biological Chemistry, 274 (5) :2920-2928.
[31]	Imbrogno S, Garofalo F, Cerra MC (2010). The catecholamine release-inhibitory peptide catestatin (chromogranin A344-364) modulates myocardial function in fish. The Journal of Experimental Biology, 213: 3636-3643.
[32]	Angelone T, Quintieri AM, Bhawanjit K (2008). The Antihypertensive Chromogranin A Peptide Catestatin Acts as a Novel Endocrine/Paracrine Modulator of Cardiac Inotropism and Lusitropism. Endocrinology, 149(10):4780-4793.
[33]	Tsigelny IF, Kouznetsova VL, Biswas N.MahataSK, and OConnor DT (2013). Development of a pharmacophore model for the chatecholamine release- inhibitory peptide catestatin: Virtiual screening and functional testing identify novel small molecule therapeutics of hypertension. Bioorganic and Medicinal Chemistry, 21(18):5855-5869.
[34]	Taupenot L, Harper KL, and Oconnor DT (2003). The chromogranin- secretogranin family. N Engl J Med, 348(12):1134-49.
[35]	O’Connor DT, Kailasam MT, and Kennedy BP (2002). Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens, 20:1335-45.